Drugs / GHRP-1/AG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00381602 | Sep 2006 → May 2007 | end stage renal failure | QLT Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GHRP-1/AG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00381602 ↗ |
| Route | Subcutaneous | “Subjects will receive single subcutaneous injections of the active GHRP-1/AG study treatment” NCT00381602 ↗ |